Immunogenomic dynamics and biomarkers in patients with hepatocellular carcinoma receiving immunotherapy
Not Applicable
- Conditions
- Neoplasms
- Registration Number
- KCT0005305
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
1) Patients with histologically confirmed HCC,
2) Patients with histologically confirmed locally advanced, recurrent or metastatic HCC, which was judged not to be eligible for surgical resection, liver transplantation or radiofrequency ablation
3) Patients who will receive immuno-oncology treatment
Exclusion Criteria
1) Patients with histologically confirmed fibrolamellar type HCC, sarcomatoid HCC, or mixed cholangiocarcinoma and HCC
2) Patients with concurrent other malignancy
3) Patients who are candidates for local curative treatments such as hepatic resection, liver transplantation, or radiofrequency ablation
4) Patients who have a possibility of confusion in the results of the clinical research
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method treatment response
- Secondary Outcome Measures
Name Time Method Overall survival